1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim report from a phase 2 multicenter study of tazemetostat, an EZH2 inhibitor, in patients with relapsed or refractory B-cell non-Hodgkin lymphomas
    Meeting Abstract

    Morschhauser, F.; Salles, G.; McKay, P.; Tilly, H.; Schmitt, A.; Gerecitano, J.; Johnson, P.; Le Gouill, S.; Dickinson, M. J.; Fruchart, C.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Chronic lymphocytic leukemia: Individualizing treatment approach
    Journal Article

    Zelenetz, A. D.
    Journal of the National Comprehensive Cancer Network (2017)

    Fulltext@MSK | Save
  • Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies
    Journal Article

    Karantanos, T.; Politikos, I.; Boussiotis, V. A.
    Blood and Lymphatic Cancer: Targets and Therapy (2017)

    Fulltext@MSK | Save
  • The role of therapeutic layering in optimizing treatment for patients with castration-resistant prostate cancer (prostate cancer radiographic assessments for detection of advanced recurrence II)
    Journal Article

    Crawford, E. D.; Petrylak, D. P.; Shore, N.; Saad, F.; Slovin, S. F.; Vogelzang, N. J.; Keane, T. E.; Koo, P. J.; Gomella, L. G.; O'Sullivan, J. M.; more...
    Urology (2017)

    Fulltext@MSK | Save
  • Patient perspectives on ipilimumab across the melanoma treatment trajectory
    Journal Article

    Shuk, E.; Shoushtari, A. N.; Luke, J.; Postow, M. A.; Callahan, M.; Harding, J. J.; Roth, K. G.; Flavin, M.; Granobles, A.; Christian, J.; more...
    Supportive Care in Cancer (2017)

    Fulltext@MSK | Save
  • The landscape of new drugs in lymphoma
    Journal Article

    Younes, A.; Ansell, S.; Fowler, N.; Wilson, W.; De Vos, S.; Seymour, J.; Advani, R.; Forero, A.; Morschhauser, F.; Kersten, M. J.; more...
    Nature Reviews Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells
    Journal Article

    Vu, L. P.; Prieto, C.; Amin, E. M.; Chhangawala, S.; Krivtsov, A.; Calvo-Vidal, M. N.; Chou, T.; Chow, A.; Minuesa, G.; Park, S. M.; more...
    Nature Genetics (2017)

    Fulltext@MSK | Save
  • Hiding in plain sight: Immune escape in the era of targeted T-cell-based immunotherapies
    Journal Article

    Daniyan, A. F.; Brentjens, R. J.
    Nature Reviews Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Where do the new drugs fit in for relapsed/refractory Hodgkin lymphoma?
    Journal Article

    Khan, N.; Moskowitz, A. J.
    Current Hematologic Malignancy Reports (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in older patients with myelodysplastic syndromes
    Journal Article

    Getta, B. M.; Kishtagari, A.; Hilden, P.; Tallman, M. S.; Maloy, M.; Gonzales, P.; Castro-Malaspina, H.; Perales, M. A.; Giralt, S.; Tamari, R.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save